TY - JOUR
T1 - Obesity and the Polycystic Ovary Syndrome
AU - Magnotti, Michael
AU - Futterweit, Walter
PY - 2007/11
Y1 - 2007/11
N2 - Polycystic ovarian syndrome (PCOS) is extremely common among reproductive-aged women, but often goes undiagnosed. PCOS is associated with the metabolic syndrome and carries a greatly increased risk of impaired glucose tolerance and type 2 diabetes mellitus, and cardiovascular risks. Treatment of PCOS may provide relief of cosmetic problems and depression by improving patient self-esteem. In addition, because of its association with the metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease, its recognition and treatment can potentially be life saving. This article reviews the impact, pathophysiology, and associated risks of obesity and the metabolic syndrome in PCOS.
AB - Polycystic ovarian syndrome (PCOS) is extremely common among reproductive-aged women, but often goes undiagnosed. PCOS is associated with the metabolic syndrome and carries a greatly increased risk of impaired glucose tolerance and type 2 diabetes mellitus, and cardiovascular risks. Treatment of PCOS may provide relief of cosmetic problems and depression by improving patient self-esteem. In addition, because of its association with the metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease, its recognition and treatment can potentially be life saving. This article reviews the impact, pathophysiology, and associated risks of obesity and the metabolic syndrome in PCOS.
UR - https://www.scopus.com/pages/publications/35448929866
U2 - 10.1016/j.mcna.2007.06.010
DO - 10.1016/j.mcna.2007.06.010
M3 - Review article
C2 - 17964914
AN - SCOPUS:35448929866
SN - 0025-7125
VL - 91
SP - 1151
EP - 1168
JO - Medical Clinics of North America
JF - Medical Clinics of North America
IS - 6
ER -